Are Moderna’s Coronavirus Gains Over?

Moderna (NASDAQ:MRNA) shares skyrocketed 309% this year to a record high on May 18 as investors bet on the company's investigational coronavirus vaccine. But sentiment hasn't been so great in recent days, and the stock dropped 35% from that high.